What Real Analysts Say About AI Research Tools (Unfiltered)

Rogo: 'not ready for prime time.' Hebbia: 'insanely expensive.' AlphaSense: 'frequently incomplete.' Unfiltered analyst reviews vendors will not show you.

TL;DR

  • AI research tools in finance are useful assistants and unreliable producers. They accelerate thinking. They do not replace it.
  • The “hallucination tax”: if a tool takes 5 minutes to generate an answer and 20 minutes to verify, the net time savings are thin
  • Every major platform shares the same structural gap: useful for internal research, unable to produce client-ready deliverables without heavy human editing
  • SaaS tools serving thousands of users produce generic analysis. The differentiated work that defines a fund’s edge requires custom infrastructure.
  • Budget guidance: $3,300/seat (Rogo) or $20,000/seat (Hebbia) makes sense for research acceleration. It does not make sense if the expectation is deliverable output at scale.

The Gap Between Marketing and the Analyst Reviews

Every AI research platform in finance tells the same story: massive time savings, instant insights, thousands of data sources synthesized in seconds. The marketing pages are polished. The case studies are carefully selected. The ROI figures are self-reported and unverified.

Then you read the reviews.

Wall Street Oasis forums, G2, Gartner Peer Insights, and Reddit threads from working analysts paint a different picture. Not uniformly negative. But consistently divergent from the vendor narrative in ways that matter for anyone allocating budget to these tools.

Here is what the people actually using these platforms say about them.

Rogo: $750 Million Valuation, 25,000 Users

Rogo raised a $75 million Series C led by Sequoia in January 2026 at a $750 million valuation. Backers include Tiger Global, J.P. Morgan, Thrive Capital, Khosla Ventures, and Henry Kravis personally. The platform serves 25,000 finance professionals at firms including Rothschild, Jefferies, Lazard, Moelis, and Nomura. Pricing runs approximately $3,300 per seat per year on multi-year contracts.

The marketing claim: 10+ hours saved weekly on meeting prep, company profiling, and market research. ISO/IEC 42001 certified. 65 million sources including SEC filings, S&P Global data, FactSet, Crunchbase, and live news.

What analysts at Lazard say: “Not ready for prime time, more focused on selling a dream.”

What analysts at Lazard and Moelis say collectively: “Mediocre and underwhelming.”

An anonymous investment banking analyst: “A pretty [bad] ChatGPT wrapper that has access to CapIQ” that “also hallucinates sometimes,” requiring manual verification of deal values.

On the deliverability problem: The recurring complaint is not that Rogo gives wrong answers. It is that the answers are not usable. “Its main use case appears to be summarizing earnings updates” but “doesn’t actually produce anything they can submit to a client or partner.” The output is useful for getting up to speed on an unfamiliar company. It falls apart when the analyst needs to produce something that leaves the building.

The context window limitation: Sacra’s independent analysis noted that Rogo “can’t reliably scale analysis over thousands of documents, including a firm’s past deals, because LLMs still have limited context windows.” This is a structural constraint, not a bug to be fixed. The platform processes individual queries well. It struggles when the analysis requires connecting information across a large corpus of internal documents.

Rogo’s response has been acquisitive. They acquired Subset in September 2025 for spreadsheet agent capabilities and Offset in March 2026 for “learning agents” that develop memory about how financial models are constructed. Both acquisitions acknowledge the gap between research chatbot and production infrastructure. Whether they close that gap while serving 25,000 users with different workflows at $3,300 per seat is the open question.

Hebbia: $700 Million Valuation, $15 Trillion in AUM Decisions

Hebbia raised $130 million in a Series B led by a16z in July 2024 at a $700 million valuation. The platform uses a multi-agent framework with a distinctive grid interface: documents are rows, questions are columns, AI-generated answers fill the cells. Every output includes inline citations. The company claims over 40% of the largest asset managers by AUM as clients.

Pricing is not publicly available but estimated around $20,000 per seat per year. No free trial. No self-serve access.

G2 and community feedback on practical limitations: The Google Drive integration “didn’t work well enough.” Excel integration was “still early.” File management was “not easy.” The platform could not export to Word or PDF.

The reliability concern: Users described the platform as “not reliable enough” for production workflows where output consistency matters.

The pattern: Hebbia excels at internal exploration. Upload a stack of documents, ask questions across all of them, get cited answers. For due diligence, CIM review, and contract analysis, the grid interface is genuinely useful. The problems emerge at the edges: getting data into the platform from existing systems, getting results out in formats other teams can use, and maintaining consistency across sessions.

One reviewer summarized the dynamic: Hebbia is “insanely expensive” relative to what it reliably produces. The per-seat cost makes sense for workflows where exploring a document corpus is the primary task. It makes less sense for teams that need AI embedded into their existing workflows rather than replacing those workflows with a new interface.

AlphaSense: The Incumbent’s Growing Pains

AlphaSense is the established player: 300 million documents, NLP-powered search, expert network integration through its Tegus acquisition. The broadest coverage of any platform in the space.

Gartner Peer Insights reviewers: “Financials section frequently incomplete, stale, or has errors.” Filters break. The learning curve is steep. Support is inconsistent. Contract terms are strict at 90 days.

The interface criticism: “Old UI” appeared repeatedly. For a platform charging enterprise prices, the user experience has not kept pace with newer competitors.

The data reliability issue: When reviewers flag that financial data is “incomplete, stale, or has errors,” they are describing a trust problem. An analyst who cannot rely on the platform’s financials will verify everything manually. At that point, the tool becomes a search engine rather than a research assistant. It narrows where you look. It does not reduce the work of verification.

AlphaSense’s strength remains coverage breadth. Nothing else in the market offers 300 million documents plus expert network transcripts in one search. The question is whether breadth compensates for depth issues, and that depends entirely on the use case. For quick orientation on an unfamiliar topic, AlphaSense works. For building an investment thesis with numbers you plan to put in front of a committee, the verification step remains mandatory.

Three Structural Patterns Across All Platforms

These are not individual product failures. They represent a structural gap between what AI research tools promise and what the current generation can deliver.

The Deliverability Gap

This phrase appeared across reviews of both Rogo and Hebbia. AI tools are useful for the analyst’s internal thinking process. They consistently fall short of producing something that can be handed to a client, a portfolio manager, or an investment committee without significant human editing. The gap is not just formatting. It is judgment: knowing which details matter, how to frame uncertainty, what the audience already knows, and what will trigger follow-up questions.

The Hallucination Tax

Every analyst using these tools manually verifies critical data points. This is rational and necessary given current model capabilities. But the verification step undercuts the time-savings claim. If the tool takes 5 minutes to produce an answer and the analyst spends 20 minutes confirming it, the net savings over doing the research manually are thin. The “10+ hours saved weekly” figures assume the analyst trusts the output enough to use it directly. Real-world usage suggests they do not, and should not.

The Generic Analysis Problem

SaaS tools serving thousands of users necessarily produce generic analysis. Rogo gives the same analytical framework to Tiger Global as it gives to a regional bank. AlphaSense surfaces the same documents for every subscriber. This works for commodity research tasks. It fails for the differentiated analysis that is the entire purpose of a research team at a serious fund.

The implication: off-the-shelf tools cover the base layer of research. The differentiated layer, where a firm’s proprietary methodology and competitive advantage live, requires infrastructure that understands that specific firm’s workflow. For the strategic framework on when to buy vs build that infrastructure, see our build vs buy analysis.

What the Reviews Tell You About Budget Allocation

Reading analyst reviews of AI tools is useful not because they reveal which product is best. They reveal what the category can and cannot do in its current state.

What works today: Getting up to speed on unfamiliar companies quickly. Summarizing earnings calls. Basic company profiling. Initial due diligence on a stack of documents. Quick lookups during calls or meetings. These are real time-savers, and analysts who use these tools for these purposes generally find them useful.

What does not work today: Producing client-ready deliverables. Encoding firm-specific investment methodology. Scaling analysis reliably across thousands of internal documents. Maintaining consistency session to session. Replacing any workflow where the output needs to be trusted without manual verification.

The honest evaluation is that AI research tools in finance are useful assistants and unreliable producers. They accelerate the thinking process. They do not replace it. They compress the time spent gathering information. They do not compress the time spent judging what that information means.

For budget allocation purposes: a $3,300 Rogo seat or a $20,000 Hebbia seat makes sense if the primary use case is research acceleration for individual analysts. It does not make sense if the expectation is deliverable output at scale without significant human involvement. The reviews are clear on this. The marketing is not.


Frequently Asked Questions

Are these AI research tools worth the cost?

For research acceleration (getting up to speed on companies, summarizing earnings, quick lookups), yes. For deliverable output that goes to clients or investment committees without heavy editing, the reviews consistently say no. Match the tool to the use case, not the marketing promise.

Why do analysts still manually verify AI-generated research?

Because the tools hallucinate. Specific deal values, financial figures, and date attributions can be wrong in ways that are plausible enough to miss on casual reading. At $3,300-$20,000 per seat, the expectation might be production-quality output. The reality is that every critical data point requires a separate verification step. This is the “hallucination tax.”

Which platform is best for due diligence workflows?

Hebbia’s grid interface (documents as rows, questions as columns, cited answers in cells) is the strongest current offering for exploring a document corpus. The limitation is getting data in (Drive integration issues) and results out (no Word/PDF export). For due diligence specifically, the per-seat cost may be justified. For broader research needs, the limitations are more visible.

Can these tools encode a firm’s proprietary research methodology?

Not in their current SaaS form. They serve thousands of users with the same analytical framework. A credit fund’s internal evaluation found that generic tools cover 80% of use cases, but the remaining 20% where proprietary methodology lives requires custom infrastructure. Rogo’s Offset acquisition (March 2026) aims to address this with “learning agents” that develop memory of firm-specific model construction, but it is early.

How should a fund evaluate these tools before committing budget?

Request a pilot (not a demo) with real analysts on real workflows for a minimum of 30 days. Track: (1) time saved per task, (2) verification time per AI-generated output, (3) percentage of output usable without editing, (4) tasks where the tool was not used despite availability. The gap between (1) and (2) reveals the true time savings. Metric (4) reveals where the tool does not fit the actual workflow.


Sources: Rogo Series C ($75M, Sequoia, Jan 2026, $750M valuation), Hebbia Series B ($130M, a16z, Jul 2024, $700M valuation), Wall Street Oasis analyst reviews (2025-2026, Rogo threads), G2 reviews (Hebbia, 2025-2026), Gartner Peer Insights (AlphaSense, 2025-2026), Sacra independent Rogo analysis (context window limitations), Resonanz Capital “How Hedge Funds Are Really Using Generative AI”

Last updated: April 14, 2026

If your team is evaluating AI research tools and wants an honest technical assessment before committing budget, we’d welcome that conversation.

By BetterAI | We build custom AI research infrastructure for European investment firms. See how it works